Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Androgen Independent Prostate Cancer”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Large-scale testing (Phase 3)Study completedNCT00286091
What this trial is testing

Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Amgen 1,435
Testing effectiveness (Phase 2)Study completedNCT00005857
What this trial is testing

Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00052000
What this trial is testing

A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00136526
What this trial is testing

Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT00849290
What this trial is testing

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Who this might be right for
Metastatic Androgen Independent Prostate Cancer
Dendreon 113
Testing effectiveness (Phase 2)Study completedNCT00068731
What this trial is testing

Lycopene in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Study completedNCT00599313
What this trial is testing

Phase II Sunitinib Prog Met AIPC

Who this might be right for
Metastatic Prostate Cancer
US Oncology Research 36
Testing effectiveness (Phase 2)Study completedNCT00814788
What this trial is testing

Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, Davis 24
Testing effectiveness (Phase 2)Study completedNCT00390468
What this trial is testing

Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerPainProstate Cancer
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00070837
What this trial is testing

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Millennium Pharmaceuticals, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT00072930
What this trial is testing

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
MedImmune LLC 150
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT00005828
What this trial is testing

Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 54
Testing effectiveness (Phase 2)Ended earlyNCT00080782
What this trial is testing

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00901342
What this trial is testing

Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 104
Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Testing effectiveness (Phase 2)Study completedNCT00634647
What this trial is testing

Satraplatin and Prednisone to Treat Prostate Cancer

Who this might be right for
Prostate CancerGenetic Polymorphism
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00003256
What this trial is testing

Flavopiridol in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00520481
What this trial is testing

Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Eli Lilly and Company 41
Early research (Phase 1)Ended earlyNCT00096304
What this trial is testing

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 36
Load More Results